Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001855763-22-000019)

Filing Details

Accession Number:: 0001855763-22-000019
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-10-18 18:20:31
Reporting Period:: 2022-10-12

Accepted Time:: 2022-10-18 18:20:31
Original Submission Date:: 2022-10-13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348362	Lexaria Bioscience Corp.	LEXX	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1103780	Christopher Bunka	1924 Birkdale Ave Kelowna A1 V1P1R7	Chief Executive Officer	Yes	Yes	No	No

Transaction Summary

Purchased:	38,500 shares	Avg. Price: $2.04	Total Value: $78,397.20
Number of Shares After Transactions:	254,412 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2022-10-12	21,900	$1.99	237,812	No	4	P	Indirect	Private Holding Company
Common Shares	Acquisiton	2022-10-13	16,600	$2.10	254,412	No	4	P	Indirect	Private Holding Company

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Private Holding Company
No	4	P	Indirect	Private Holding Company

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	273,543	Direct
Common Shares	215,912	Indirect	Private Holding Company

Footnotes

This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022.